Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
26343 | 211 | 22.3 | 52% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
917 | 10527 | EVIDENCE BASED MEDICINE//BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION//PUBLICATION BIAS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RUN IN PERIOD | Author keyword | 3 | 60% | 1% | 3 |
2 | THERAPEUTIC INFORMATION | Author keyword | 3 | 60% | 1% | 3 |
3 | RUN IN | Author keyword | 2 | 38% | 2% | 5 |
4 | EFFECT MODEL | Author keyword | 2 | 36% | 2% | 5 |
5 | INFORMATION ON THERAPEUTICS | Author keyword | 1 | 100% | 1% | 2 |
6 | PERTINENT INFORMATION | Author keyword | 1 | 100% | 1% | 2 |
7 | THERAPY TARGET POPULATION | Author keyword | 1 | 100% | 1% | 2 |
8 | UNITE PHARM CLIN | Address | 1 | 100% | 1% | 2 |
9 | ABCDE BUNDLE | Author keyword | 1 | 50% | 0% | 1 |
10 | ACTUAL BENEFIT | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RUN IN PERIOD | 3 | 60% | 1% | 3 | Search RUN+IN+PERIOD | Search RUN+IN+PERIOD |
2 | THERAPEUTIC INFORMATION | 3 | 60% | 1% | 3 | Search THERAPEUTIC+INFORMATION | Search THERAPEUTIC+INFORMATION |
3 | RUN IN | 2 | 38% | 2% | 5 | Search RUN+IN | Search RUN+IN |
4 | EFFECT MODEL | 2 | 36% | 2% | 5 | Search EFFECT+MODEL | Search EFFECT+MODEL |
5 | INFORMATION ON THERAPEUTICS | 1 | 100% | 1% | 2 | Search INFORMATION+ON+THERAPEUTICS | Search INFORMATION+ON+THERAPEUTICS |
6 | PERTINENT INFORMATION | 1 | 100% | 1% | 2 | Search PERTINENT+INFORMATION | Search PERTINENT+INFORMATION |
7 | THERAPY TARGET POPULATION | 1 | 100% | 1% | 2 | Search THERAPY+TARGET+POPULATION | Search THERAPY+TARGET+POPULATION |
8 | ABCDE BUNDLE | 1 | 50% | 0% | 1 | Search ABCDE+BUNDLE | Search ABCDE+BUNDLE |
9 | ACTUAL BENEFIT | 1 | 50% | 0% | 1 | Search ACTUAL+BENEFIT | Search ACTUAL+BENEFIT |
10 | BAYESIAN OUTLIER DETECTION | 1 | 50% | 0% | 1 | Search BAYESIAN+OUTLIER+DETECTION | Search BAYESIAN+OUTLIER+DETECTION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PREPUBLICATION RELEASE | 1 | 40% | 1% | 2 |
2 | ANEURYSM SURGERY TRIAL | 1 | 50% | 0% | 1 |
3 | PHYSIODIRECT TELEPHONE ASSESSMENT | 1 | 50% | 0% | 1 |
4 | INFLUENCE MEDICAL PRACTICE | 1 | 20% | 1% | 3 |
5 | CARE COORDINATION HOME TELEHEALTH | 0 | 14% | 0% | 1 |
6 | EFFECT MODEL | 0 | 14% | 0% | 1 |
7 | PLACEBO RUN IN | 0 | 14% | 0% | 1 |
8 | INFARCTION PATIENTS | 0 | 13% | 0% | 1 |
9 | EPIDEMIOLOGIC CONTEXT | 0 | 10% | 0% | 1 |
10 | STROKE STATISTICS 2013 UPDATE | 0 | 10% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
INFORMATION ON THERAPEUTICS - HOW TO TRANSFER THE ACTUAL STATE OF KNOWLEDGE | 1994 | 6 | 47 | 21% |
Association of run-in periods with weight loss in obesity randomized controlled trials | 2014 | 0 | 7 | 29% |
PRESENTATION OF THE RESULTS OF A GENERAL-REVIEW | 1993 | 0 | 12 | 42% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNITE PHARM CLIN | 1 | 100% | 0.9% | 2 |
2 | CLIN PHARMACOL EA643 | 1 | 50% | 0.5% | 1 |
3 | MD ANDERSON CANCER EPIDEMIOL | 1 | 50% | 0.5% | 1 |
4 | REG ANTICANC | 1 | 50% | 0.5% | 1 |
5 | EA643 | 1 | 22% | 0.9% | 2 |
6 | CIC 201 | 0 | 15% | 0.9% | 2 |
7 | AFS | 0 | 25% | 0.5% | 1 |
8 | PUBL HLTH BIOMETRY | 0 | 25% | 0.5% | 1 |
9 | PUBL HLTH SCI HLTH POLICY MANAGEMENT EVA | 0 | 20% | 0.5% | 1 |
10 | RTH LAENNEC MED | 0 | 20% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000100118 | ACADEMIC DETAILING//DRUG UTILIZATION REVIEW//ADVANCED PULMONARY DISEASE |
2 | 0.0000083095 | REGIME AMPI//SERV MED ASSURANCE MALAD//ECHELON |
3 | 0.0000080710 | CONSORT//OTTAWA METHODS//REPORTING QUALITY |
4 | 0.0000079910 | CEREBRAL ISCHEMIA PREVENTION AND CONTROL//INFORMAT METR STUDIES//GR H REP ENTAT |
5 | 0.0000078654 | INTERNATIONAL CLINICAL RESEARCH//ACTUAL BENEFIT//CHILD ABUSE HOMICIDE |
6 | 0.0000078140 | NUMERACY//RISK COMMUNICATION//RISK LITERACY |
7 | 0.0000069530 | COLLATERAL CORONARY FLOW//ADV MED TRAINING STATE//BETA BLOCKER |
8 | 0.0000069472 | MIXED TREATMENT COMPARISONS//NETWORK META ANALYSIS//RESEARCH SYNTHESIS METHODS |
9 | 0.0000069226 | YALE CHEM//CONSEQUENCES ANALYSIS//DATA TRANSFERABILITY |
10 | 0.0000068605 | BRIDGING STUDY//MULTIREGIONAL CLINICAL TRIAL//MULTIREGIONAL TRIAL |